Diabetes is a growing concern all over the world. Studies have shown that more than 230 million people worldwide are affected by it. In the Philippines, 3.4 million people are afflicted with diabetes, half of whom are below 19 years of age, and one out of 10 persons will die of the disorder.
Novo Nordisk, a leader in diabetes care and research, aims to constantly provide better information, products and services. The company, under the leadership of country manager Rex Laroza, has launched the Changing Diabetes program with a three-pronged agenda focusing on education, services and products in cooperation with Diabetes Philippines, as headed by Dr. Tommy Ty-Willing. Novo Nordisk Philippines sponsored a seminar to educate the layman about the disorder.
At the forum, the country’s most popular diabetic, Gary Valenciano, said, “These days, diabetes hits people younger and younger. There is a need for education, especially (among) those who are from the provinces who don’t get the proper diagnosis.”
Experts also came together to better educate the public on healthy living lifestyles. One of the country’s leading endocrinologists, Dr. Richard Elwyn Fernando, spoke about the risk of supplements. Renowned nutritionist Imelda Cardino discussed how to lower glycemic index, and sports nutritionist Sanirose Orbeta spoke about the dangers of fad diets.
Detection and risk
Although diabetes can afflict anyone, people with the greatest risk are those with a family history of the disorder. Asians are also more predisposed to getting the disorder. According to the Diabetes Federation, the growing number of diabetes can be attributed to the change in today’s lifestyle — the proliferation of sugar-rich and fatty food in the market as well as a promotion of a sedentary lifestyle.
Contributing to that are people who lack exercise, have an unhealthy diet and are overweight. Should anyone fall under these categories, one should be on the watch for the following warning signs: Frequent urination, weight loss, lack of energy, tiredness, lack of interest and concentration, vomiting and stomach pain, a tingling or numbness in the hands and feet, blurred vision and slow-healing wounds, as well as excessive thirst.
If any combination of these signs is observed, one should get a blood sugar test to determine the possibility of the disorder. It is not a lost cause, however, for people who are classified high-risk. Prevention efforts can delay or avoid the onset of type 2 diabetes.
Risk reduction
Novo Nordisk, along with Dr. Ty-Willing, has been teaching people to lower the risk for diabetes, as well as educate diabetes sufferers on a healthy living lifestyle. Dr. Ty-Willing has even devised the three Ks to avoid: katabaan, katamaran, katakawan.
To reduce one’s risk for the disorder, one should maintain a healthy diet, eat in moderation and adopt a healthy exercise habit like brisk walking, dancing, swimming and cycling. Thirty minutes of these aerobic exercises a day can reduce diabetes risk up to 40 percent.
Dr. Fernando discussed risk of replacing medication with dietary supplements being sold in the market. He stressed on the fact that these supplements do not heal, cure or prevent any disorder or disease. Particularly, these “herbal supplements” can only lower the blood sugar levels by 10 units — not enough to manage the disorder.
Dr. Ty-Willing further clarified the “no therapeutic claim” by translating in Filipino as “ang produktong ito ay hindi nakakagamot ng anumang klaseng sakit.” He stressed that the supplement companies were granted licenses to produce food supplements only, not medication. He stressed the need for discernment with the purchase and usage of these supplements, as well as the generic medicine available.
To solidify his point, Dr. Ty-Willing further said that to control the disorder, oral anti-diabetics are virtually useless. In fact, taking this type of medication further leads to destruction of beta-cells — the insulin producing cell in the pancreas.
Deadly diet
Sports nutritionist Sanirose Orbeta discussed the fad diets as part of the discussion of healthy living. She stresses that these fad diets wreak havoc to the body and can cause more harm than good. In fact, she will never prescribe these fad diets to diabetes-afflicted people because studies have shown rapid weight lost with fad diets are purely water loss. The loss of water can cause dehydration and damage to the kidney, heart and liver.
The ideal diet for diabetics is to have a mixed diet that is limited to 1,500 calories a day. She explained that carbohydrates are the food of the pancreas and too much protein wreak havoc to insulin production. As a result, meals should always be planned to have 25 percent carbohydrates, moderate fat and less protein. To safely measure protein consumption, she stresses that the portion of meat should not exceed the size of one’s palm.
Orbeta strongly suggested that one can achieve proper weight loss and maintenance with a good diet by simply restricting overall calorie intake. She ended her talk by saying, “All food can fit in (your diet) in moderation. If you eat less and move more, you will live longer.”
Changing diabetes
The necessity for Modern Insulin is high globally, most prevalently in Europe and America. Comparatively, our country has yet to increase awareness on the advantages of this and improve utilization. Few understand and realize that treatment today is as simple as clicking an instrument such as NovoNordisk’s Flexpen.
Today, Novo Nordisk offers the most complete line of diabetes products available. Dependable modern insulin therapies such as Levemir, NovoMix 30 and Novorapid. Levemir is the latest modern basal insulin analog in the market launched last year, which offers a 24-hour basal insulin and a proven better-safety profile. Novo Nordisk also offers insulatard and mixtard in novolets and vials.
With their unending commitment to make a difference, Novo Nordisk supported a local Philippine trial called Fact and Safe trial to further establish the safety and efficacy of modern insulin among Filipinos.
Novo Nordisk as the world’s leading manufacturer of Insulin focusing on R&D in diabetes care. The company develops products such as the Flexpen and Novofine needles that reduce, and sometimes eliminate, the pain of injection. With products like these, the fear of diabetes treatment is reduced to a level where insulin injection is not feared, but welcomed. The Daily Tribune






